Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Recurrent C. difficile Infection: Expert Perspectives on Impacting Clinical Outcomes and Economics

Access Activity

Overview / Abstract:

This CME activity addresses the management of recurrent Clostridium difficile infection (CDI), including identification of at-risk patients, evidence-based treatment, and its economic impact. In this text-based interview, two faculty will discuss their approaches to the prevention and management of recurrent CDI. This is the second in a series of five educational activities on CDI to be released in 2017.

This activity is intended for gastroenterologists, infectious disease specialists, and other healthcare professionals that treat C. difficile infections.

Upon completion of this curriculum, participants will be able to:
• Identify patients who may be at increased risk for recurrent C. diff infection
• Assess the clinical efficacy and safety of biologics for prevention of recurrent CDI
• Outline evidence-based approaches for the management of first, second, and third recurrences of C. diff in diverse patient populations

Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Further, recurrence of CDI is common after an initial episode. Although a number of therapies with varying mechanisms of action, are available to treat CDI and prevent recurrence, the management of recurrent CDI is complex and challenging. Clinicians require up-to-date knowledge of evidence-based treatment of recurrent CDI to reduce its burden and improve clinical outcomes.

Expiration

Jun 30, 2018

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Podcast, Webinar / Webcast / Video

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)(TM)

Accreditation

ACCME

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

David Binion, MD
Professor of Medicine, Clinical and Translational Science
Co-Director, IBD Center – Translational Research
Director, Nutrition Support Service
Division of Gastroenterology, Hepatology, and Nutrition
University of Pittsburgh
UPMC Presbyterian Hospital
Pittsburgh, PA

James Lewis, II, PharmD, FIDSA
Infectious Disease Clinical Pharmacy Supervisor
Co-Director of Antibiotic Stewardship
Department of Pharmacy
Oregon Health & Science University
Portland, OR

Activity Specialities / Related Topics

Contamination & Infection Control, Critical Care / Intensive Care, Education / Teaching, Emergency Medicine, Gastroenterology / GI, Geriatrics / LTC, Infectious Disease, Internal Medicine, Primary Care, Surgery

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Merck & Company.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Interview, Case Study, CDI, CDI Interview, Clostridium difficile, C. diff, David Binion, James Lewis, recurrent CDI, Merck, online CME, gastroenterology, infectious diseases, prevent CDI, Dave Binion, Jim Lewis, recurrent C. difficile, recurrent Clostridium difficile, recurrent CDI, prevention, CDI treatment, Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map